Related Experiment Video
Updated: Dec 3, 2025
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Gold Nanoparticles Mediated Drug-Gene Combinational Therapy for Breast Cancer Treatment
Binita Shrestha1, Lijun Wang1, Hao Zhang2
1Department of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX, USA.
Background:
Cancer is a complex heterogeneous disease to which singular modes of treatment mostly fail to produce a desired therapeutic efficacy. Targeting different cellular pathways using combinational therapies has been gaining popularity in cancer treatment, with the added benefit of reducing dosage and side effects.
Methods:
A gold nanoparticle-mediated drug delivery nanoplatform was developed for co-delivery of doxorubicin and polo-like kinase 1 (PLK1) siRNA. Gold nanoparticles were coated with polyethyleneimine to facilitate assembly of PLK1 on the surface. Doxorubicin was loaded on nanoparticles through a pH-sensitive linker with a thiol group at one terminal end for controlled release.
Results:
The therapeutic efficiency of this co-delivery system was evaluated in 2D and 3D cultured systems. The reduced IC50 value clearly demonstrated the synergistic effect of combined drug and gene delivery over their individual delivery in a cancer treatment model.
Conclusion:
This study may provide an adaptable, facile platform to investigate drug-siRNA combinations for cancer inhibition.
Insights
This study developed a gold nanoparticle platform for co-delivering doxorubicin and PLK1 siRNA, showing synergistic cancer treatment effects. This combined approach reduced dosage and improved therapeutic efficacy in cancer models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapeutics
Background:
- Cancer's heterogeneity necessitates advanced treatment strategies.
- Combinational therapies offer improved efficacy and reduced side effects.
- Targeting multiple cellular pathways is crucial for effective cancer treatment.
Purpose of the Study:
- To develop a novel gold nanoparticle-based nanoplatform for co-delivery of doxorubicin and polo-like kinase 1 (PLK1) siRNA.
- To investigate the synergistic therapeutic effects of combined drug and gene delivery in cancer treatment.
- To establish a versatile platform for exploring drug-siRNA combinations.
Main Methods:
- Fabrication of gold nanoparticles coated with polyethyleneimine for PLK1 siRNA assembly.
- Loading doxorubicin onto nanoparticles via a pH-sensitive linker for controlled release.
- Evaluation of the co-delivery system's therapeutic efficiency in 2D and 3D cancer models.
Main Results:
- The co-delivery system demonstrated a significant synergistic effect compared to individual drug or gene delivery.
- Reduced IC50 values indicated enhanced therapeutic efficacy.
- Successful co-delivery of doxorubicin and PLK1 siRNA was achieved.
Conclusions:
- The developed gold nanoparticle platform is adaptable and facile for investigating drug-siRNA combinations.
- This approach holds promise for effective cancer inhibition strategies.
- Co-delivery systems can overcome limitations of single-agent cancer therapies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:56Treatment Resistant Cancers
00:59Gene Therapy
02:18Cancer
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...